Evidence map›Paper›PMID 37431663›Full record

Trial reportHypertension (Dallas, Tex. : 1979)2023

PREPARE: A Stepped-Wedge Cluster-Randomized Trial to Evaluate Whether Risk Stratification Can Reduce Preterm Deliveries Among Patients With Suspected or Confirmed Preterm Preeclampsia.

Leandro De Oliveira, James M Roberts, Arundhathi Jeyabalan, Kasey Blount, Christopher W Redman, Lucilla Poston, Paul T Seed, Lucy C Chappell, Marcos Augusto Bastos Dias, PREPARE trial group

Registry-linked trialOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Hypertension (Dallas, Tex. : 1979), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03073317 (PREPARE, Prematurity Reduction by Pre-eclampsia Care), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03073317 nacompletednot on this map

PREPARE, Prematurity Reduction by Pre-eclampsia Care

TypeinterventionalSponsorInstituto Fernandes FigueiraRan2016 to 2020Enrolled1,250ConditionsPre-Eclampsia, Premature BirthArmsFullPIERS and sFlit/PLGF (Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio)
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Leandro De OliveiraBotucatu Medical School, Obstetrics Department, Botucatu Sao Paulo State University, SP, Brazil (L.D.O.).ORCID 0000-0002-8422-9907
James M RobertsMagee-Womens Research Institute Department of Obstetrics and Gynecology, Epidemiology and Clinical and Translational Research, Pittsburgh, PA (J.M.R., A.J., K.B.).ORCID 0000-0002-2671-3207
Arundhathi JeyabalanMagee-Womens Research Institute Department of Obstetrics and Gynecology, Epidemiology and Clinical and Translational Research, Pittsburgh, PA (J.M.R., A.J., K.B.).
Kasey BlountMagee-Womens Research Institute Department of Obstetrics and Gynecology, Epidemiology and Clinical and Translational Research, Pittsburgh, PA (J.M.R., A.J., K.B.).
Christopher W RedmanNuffield Department of Obstetrics and Gynaecology, University of Oxford, United Kingdom (C.W.R.).
Lucilla PostonDepartment of Women and Children's Health, School of Life Course Sciences, King's College of London, United Kingdom (L.P., P.T.S., L.C.C.).
Paul T SeedDepartment of Women and Children's Health, School of Life Course Sciences, King's College of London, United Kingdom (L.P., P.T.S., L.C.C.).ORCID 0000-0001-7904-7933
Lucy C Chappell *Department of Women and Children's Health, School of Life Course Sciences, King's College of London, United Kingdom (L.P., P.T.S., L.C.C.).ORCID 0000-0001-6219-3379
Marcos Augusto Bastos Dias *Fernandes Figueira Institute, Rio de Janeiro, RJ, Brazil (M.A.B.D.).
PREPARE trial group
King's College London · GBMagee-Womens Research Institute · USInstituto de Medicina Integral Professor Fernando Figueira · BRMedecell (Brazil) · BRNuffield Orthopaedic Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly delivery in preterm preeclampsia may reduce the risks for the patient, but consequences of prematurity may be substantial for the baby. This trial evaluated whether the implementation of a risk stratification model could safely reduce prematurity.

methodsThis was a stepped-wedge cluster-randomized trial in seven clusters. Patients presenting with suspected or confirmed preeclampsia between 20

resultsBetween March 25, 2017 and December 24, 2019, 586 and 563 patients were analyzed in the intervention and usual care groups, respectively. The event rate was 1.09% in the intervention group, and 1.37% in the usual care group. After prespecified adjustments for variation between and within clusters over time, the adjusted risk ratio was 1.45 ([95% CI, 1.04-2.02];

conclusionsThe introduction of an intervention based on biomarkers and clinical factors for risk stratification did not lead to reductions in preterm deliveries. Further training on the interpretation of disease severity in preeclampsia and the development of additional risk stratification is needed before adoption into clinical practice. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT03073317.

Indexed as

Pre-EclampsiaBiomarkersFemaleHumansInfant, NewbornInfant, PrematurePlacenta Growth FactorPregnancyRisk AssessmentVascular Endothelial Growth Factor Receptor-1BiomarkersPlacenta Growth FactorVascular Endothelial Growth Factor Receptor-1hypertensionmorbiditypreeclampsiapreterm birth

Identifiers

PMID37431663
PMCPMC10510842
OpenAlexW4383872821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.